RARE POD Trademark

Trademark Overview

On Friday, February 12, 2021, a trademark application was filed for RARE POD with the United States Patent and Trademark Office. The USPTO has given the RARE POD trademark a serial number of 90527376. The federal status of this trademark filing is FINAL REFUSAL - MAILED as of Friday, January 5, 2024. This trademark is owned by McKesson Corporation. The RARE POD trademark is filed in the Personal, Legal & Social Services category with the following description:

Providing patient case management assistance services, namely, coordinating the procurement and administration of complex and high-cost rare and orphan specialty medications
rare pod

General Information

Serial Number90527376
Word MarkRARE POD
Filing DateFriday, February 12, 2021
Status645 - FINAL REFUSAL - MAILED
Status DateFriday, January 5, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesProviding patient case management assistance services, namely, coordinating the procurement and administration of complex and high-cost rare and orphan specialty medications
Disclaimer with Predetermined Text"RARE"

Classification Information

International Class045 - Legal services; security services for the protection of property and individuals; personal and social services rendered by others to meet the needs of individuals.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, May 17, 2021
Primary Code045
First Use Anywhere DateThursday, September 30, 2021
First Use In Commerce DateThursday, September 30, 2021

Trademark Owner History

Party NameMcKesson Corporation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressIrving, TX 75039

Trademark Events

Event DateEvent Description
Friday, January 5, 2024NOTIFICATION OF FINAL REFUSAL EMAILED
Friday, January 5, 2024FINAL REFUSAL E-MAILED
Friday, January 5, 2024FINAL REFUSAL WRITTEN
Thursday, December 7, 2023DIVISIONAL PROCESSING COMPLETE
Monday, December 12, 2022DIVISIONAL REQUEST RECEIVED
Tuesday, December 5, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, November 7, 2023ASSIGNED TO EXAMINER
Tuesday, December 13, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, December 12, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, December 12, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, December 12, 2022TEAS REQUEST TO DIVIDE RECEIVED
Tuesday, June 14, 2022NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
Sunday, June 12, 2022USE AMENDMENT ACCEPTED
Sunday, June 12, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sunday, June 12, 2022NON-FINAL ACTION E-MAILED
Sunday, June 12, 2022NON-FINAL ACTION WRITTEN
Thursday, April 7, 2022AMENDMENT TO USE PROCESSING COMPLETE
Thursday, April 7, 2022USE AMENDMENT FILED
Wednesday, April 6, 2022TEAS AMENDMENT OF USE RECEIVED
Saturday, March 19, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, March 18, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, March 18, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Saturday, September 18, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Saturday, September 18, 2021NON-FINAL ACTION E-MAILED
Saturday, September 18, 2021NON-FINAL ACTION WRITTEN
Wednesday, September 8, 2021ASSIGNED TO EXAMINER
Monday, May 17, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, February 16, 2021NEW APPLICATION ENTERED

Related Keywords

rare cost high complex orphan medications specialty administration procurement management